Saving money is wise, but investing is profitable
In accordance with the legislation of the Czech Republic, the Company provides services only to qualified investors!

Pliant Therapeutics Incorporated (PLRX) Financial results for the second quarter of 2020

12.08.2020

Net loss per share – $1.39 Revenue - $3.6 million